Stephan Hahn

11PUBLICATIONS
62CO-AUTHORS
Predictive and prognostic markersTissue engineeringMolecular targetsOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 27, 2024
Maintenance Therapy for Pancreatic Cancer, a New Approach Based on the Synergy between the Novel Agent GP-2250 (Misetionamide) and Gemcitabine.

Marie Buchholz, Britta Majchrzak-Stiller, Ilka Peters

|Nov 14, 2023
Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors.

Lampros Mavrommatis, Hyun-Woo Jeong, Urs Kindler

|Oct 13, 2023
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.

Donald P Cameron, Jan Grosser, Swetlana Ladigan

|Aug 21, 2023
Lasting response by vertical inhibition with cetuximab and trametinib in KRAS-mutated colorectal cancer patient-derived xenografts.

Timm M Reissig, Swetlana Ladigan-Badura, Anja Steinberg

|Jun 06, 2023
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.

Xin Wang, Ana P Kutschat, Joana Aggrey-Fynn

|Mar 08, 2023
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.

Feda H Hamdan, Amro M Abdelrahman, Ana Patricia Kutschat

Pageof 2

Frequent Collaborators

3 joint publications

Jens T Siveke

2 joint publications

Marie Buchholz

2 joint publications

Ilka Peters

2 joint publications

Carsten Theiss